×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Sulforaphane and Nrf2 Activation for Neuroprotection
therapeutic
4,477 words
KG: sulforaphane
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
Sulforaphane and Nrf2 Activation for Neuroprotection
💊
Therapeutic Info
Name
Sulforaphane and Nrf2 Activation for Neuroprotection
Summary
Page for Sulforaphane and Nrf2 Activation for Neuroprotection
Key Genes/Proteins
AMPK
,
LC3
,
NRF2
Related Diseases
cerebral ischemia/reperfusion injury
Related Pathways
lipophagy
Knowledge Graph
Related Hypotheses (20)
Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.51
Purinergic Signaling Polarization Control
Score: 0.55
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Microbial Inflammasome Priming Prevention
Score: 0.58
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.70
APOE-Dependent Autophagy Restoration
Score: 0.63
PARP1 Inhibition Therapy
Score: 0.58
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Epigenetic Memory Erasure via TET2 Activation
Score: 0.52
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44
Extracellular Matrix Stiffness Modulation
Score: 0.43
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
Show 15 more
Related Analyses (15)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
Show 10 more
Related Experiments (7)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 2 more
See Also (15)
Lipophagy Pathway in Neurodegeneration
mechanism · KG edge: activates
NRF2 Activator Therapy
idea · KG edge: activates
NRF2 Gene
gene · KG edge: activates
MAP1LC3A Gene
gene · KG edge: contributes_to
TFEB (Redirect)
redirect · KG edge: activates
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: inhibits
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Show 10 more
Knowledge Graph (5 edges)
sulforaphane
activates
lipophagy
sulforaphane
contributes_to
LC3
sulforaphane
activates
NRF2
sulforaphane
treats
cerebral ischemia/reperfusion injury
sulforaphane
activates
AMPK